METHOD OF TREATING GASTROESOPHAGEAL REFLUX DISEASE AND NOCTURNAL ACID BREAKTHROUGH

A method of concurrent treatment for gastroesophageal reflux disease and nocturnal acid breakthrough is described, which comprises the delivery of an GABAb receptor agonist such as 4-amino-3-(4-chlorophenyl) butanoic acid, in the evening, in a gastric retained drug delivery system.

Saved in:
Bibliographic Details
Main Authors FARA, JOHN W, COWLES, VERNE E, BERNER, BRET
Format Patent
LanguageEnglish
French
Published 05.12.2002
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A method of concurrent treatment for gastroesophageal reflux disease and nocturnal acid breakthrough is described, which comprises the delivery of an GABAb receptor agonist such as 4-amino-3-(4-chlorophenyl) butanoic acid, in the evening, in a gastric retained drug delivery system.
Bibliography:Application Number: CA20022449009